Diabetes was tied to a 3.3 times greater risk of earlier loss of walking ability in a study of amyotrophic lateral sclerosis ...
EKZ-102, an experimental oral therapy for amyotrophic lateral sclerosis (ALS), is on track to enter early clinical testing in ...
It took time for Philip to discover acceptance was key to him for living with ALS. Learn about his journey from diagnosis to ...
Although the exact causes of ALS remain unknown, both genetic and environmental factors may contribute to its development.
Life Time's Oct. 25 nationwide fundraiser for ALS research challenges participants to work out for 90 minutes.